Home Featured Page 138

Featured

Latest

Colorado’s Ibogaine Bill Could Be a Landmark — If It Respects the Plant’s Roots

Joe Moore Psychedelics Today on Leadership, Integration, and the Psychedelic Landscape

AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal

Pα+ February 2026 Psychedelic Bill Roundup

Navigating Colorado’s Regulated Psychedelic Model: Lessons From the Front Lines

PT372 – The Heroic Hearts Project: Veterans and The Impact of...

FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Healthline – Mental Health Breakthrough: The Therapeutic Benefits of Psychedelics

PsychCentral – All About Psychedelic Therapy

PsychCentral – Microdosing Psychedelics Linked to Lower Anxiety, Depression, Stress

atai Life Sciences Reports Third Quarter 2022 Financial Results and Business...

Death, Dying, and Psychedelics

5-HT2A Virtual Chemical Screen Produces New Candidate Antidepressants

PT371 – The Trickster Archetype and the Need for Comic Relief

Reunion Neuroscience Schedules Fiscal Second Quarter 2023 Conference Call for Monday,...

EDITOR PICKS

Colorado’s Ibogaine Bill Could Be a Landmark — If It Respects...

Joe Moore Psychedelics Today on Leadership, Integration, and the Psychedelic Landscape

AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Colorado’s Ibogaine Bill Could Be a Landmark — If It Respects the Plant’s Roots

Joe Moore Psychedelics Today on Leadership, Integration, and the Psychedelic Landscape

AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal

Pα+ February 2026 Psychedelic Bill Roundup

Navigating Colorado’s Regulated Psychedelic Model: Lessons From the Front Lines

PT372 – The Heroic Hearts Project: Veterans and The Impact of...

FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Healthline – Mental Health Breakthrough: The Therapeutic Benefits of Psychedelics

PsychCentral – All About Psychedelic Therapy

PsychCentral – Microdosing Psychedelics Linked to Lower Anxiety, Depression, Stress

atai Life Sciences Reports Third Quarter 2022 Financial Results and Business...

Death, Dying, and Psychedelics

5-HT2A Virtual Chemical Screen Produces New Candidate Antidepressants

PT371 – The Trickster Archetype and the Need for Comic Relief

Reunion Neuroscience Schedules Fiscal Second Quarter 2023 Conference Call for Monday,...

EDITOR PICKS

Colorado’s Ibogaine Bill Could Be a Landmark — If It Respects...

Joe Moore Psychedelics Today on Leadership, Integration, and the Psychedelic Landscape

AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY